This medication works by lowering your body mass index (BMI), reducing cravings and appetite to prevent overeating, and boosting your metabolism to help your body burn fat effectively
In March 2026, the patent protecting semaglutide, the active ingredient in Ozempic (for type 2 diabetes) and Wegovy (for obesity) - will expire in multiple emerging markets, including India, China, and Brazil
Take care and remember you've got lots of people, and not just that nurse with your b12, behind you on Wednesday
In a seminal study in diet-induced obese mice, 5-amino-1MQ administration led to a 35% reduction in mass and size, a 30% decrease in adipocyte size, and a 40% decrease in adipocyte volume in the rodents
9 Department of Pediatrics, Division of Metabolism and Childrens Research Center, University Childrens Hospital Zurich, Zurich, Switzerland
performed a retrospective case series review of oncologic FDG PET-CT scans in patients taking GLP-1 agonists